These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


88 related items for PubMed ID: 8661341

  • 1. Biotransformation of the MPTP analog trans-1-methyl-4-[4-dimethylaminophenylethenyl]-1,2,3,6-tetra- hydropyridine to a fluorescent pyridinium metabolite by intact neuroblastoma cells.
    Song X, Ehrich M, Flaherty D, Wang YX, Castagnoli N.
    Toxicol Appl Pharmacol; 1996 Apr; 137(2):163-72. PubMed ID: 8661341
    [Abstract] [Full Text] [Related]

  • 2. R-(-)-Deprenyl inhibits monocytic THP-1 cell neurotoxicity independently of monoamine oxidase inhibition.
    Klegeris A, McGeer PL.
    Exp Neurol; 2000 Dec; 166(2):458-64. PubMed ID: 11085911
    [Abstract] [Full Text] [Related]

  • 3. Pharmacological properties of the MPTP analog trans-1-methyl-4-[4-dimethylaminophenylethenyl]-1,2,3,6-tetrahydropyridine and its pyridinium metabolite in mouse brain synaptosomes: a potential visual marker for substrates of MPTP-induced neurotoxicity.
    Klein BG, Kirby ML, Freeborn ER, Bloomquist JR.
    Prog Neuropsychopharmacol Biol Psychiatry; 2001 Apr; 25(3):591-608. PubMed ID: 11370999
    [Abstract] [Full Text] [Related]

  • 4. Neurotoxicity studies with the monoamine oxidase B substrate 1-methyl-3-phenyl-3-pyrroline.
    Ogunrombi MO, Malan SF, Terre'Blanche G, Castagnoli K, Castagnoli N, Bergh JJ, Petzer JP.
    Life Sci; 2007 Jul 19; 81(6):458-67. PubMed ID: 17655878
    [Abstract] [Full Text] [Related]

  • 5. Development of fluorinated 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine analogs with potent nigrostriatal toxicity for potential use in positron emission tomography studies.
    Harik SI, Riachi NJ, Hritz MA, Berridge MS, Sayre LM.
    J Pharmacol Exp Ther; 1993 Aug 19; 266(2):790-5. PubMed ID: 8355208
    [Abstract] [Full Text] [Related]

  • 6. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine- and 1-methyl-4-(2'-ethylphenyl)-1,2,3,6-tetrahydropyridine-induced toxicity in PC12 cells: role of monoamine oxidase A.
    Basma AN, Heikkila RE, Nicklas WJ, Giovanni A, Geller HM.
    J Neurochem; 1990 Sep 19; 55(3):870-7. PubMed ID: 2384758
    [Abstract] [Full Text] [Related]

  • 7. A reactive metabolite of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine is formed in rat brain in vitro by type B monoamine oxidase.
    Corsini GU, Pintus S, Bocchetta A, Piccardi MP, Del Zompo M.
    J Pharmacol Exp Ther; 1986 Aug 19; 238(2):648-52. PubMed ID: 3488394
    [Abstract] [Full Text] [Related]

  • 8. D-deprenyl protects nigrostriatal neurons against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced dopaminergic neurotoxicity.
    Muralikrishnan D, Samantaray S, Mohanakumar KP.
    Synapse; 2003 Oct 19; 50(1):7-13. PubMed ID: 12872288
    [Abstract] [Full Text] [Related]

  • 9. Toxicity of MPTP and structural analogs in clonal cell lines of neuronal origin expressing B type monoamine oxidase activity.
    Buckman TD.
    Mol Chem Neuropathol; 1991 Oct 19; 15(2):87-102. PubMed ID: 1776993
    [Abstract] [Full Text] [Related]

  • 10. Species-dependent differences in monoamine oxidase A and B-catalyzed oxidation of various C4 substituted 1-methyl-4-phenyl-1,2,3, 6-tetrahydropyridinyl derivatives.
    Inoue H, Castagnoli K, Van Der Schyf C, Mabic S, Igarashi K, Castagnoli N.
    J Pharmacol Exp Ther; 1999 Nov 19; 291(2):856-64. PubMed ID: 10525109
    [Abstract] [Full Text] [Related]

  • 11. CEP-1347/KT-7515, an inhibitor of c-jun N-terminal kinase activation, attenuates the 1-methyl-4-phenyl tetrahydropyridine-mediated loss of nigrostriatal dopaminergic neurons In vivo.
    Saporito MS, Brown EM, Miller MS, Carswell S.
    J Pharmacol Exp Ther; 1999 Feb 19; 288(2):421-7. PubMed ID: 9918541
    [Abstract] [Full Text] [Related]

  • 12. (-)-Deprenyl protection of 1-methyl-4 phenylpyridium ion (MPP+)-induced apoptosis independent of MAO-B inhibition.
    Le W, Jankovic J, Xie W, Kong R, Appel SH.
    Neurosci Lett; 1997 Mar 21; 224(3):197-200. PubMed ID: 9131670
    [Abstract] [Full Text] [Related]

  • 13. Comparative aromatic hydroxylation and N-demethylation of MPTP neurotoxin and its analogs, N-methylated beta-carboline and isoquinoline alkaloids, by human cytochrome P450 2D6.
    Herraiz T, Guillén H, Arán VJ, Idle JR, Gonzalez FJ.
    Toxicol Appl Pharmacol; 2006 Nov 01; 216(3):387-98. PubMed ID: 16870220
    [Abstract] [Full Text] [Related]

  • 14. Measurement of mitochondrial respiration in permeabilized murine neuroblastoma (N-2alpha) cells, a simple and rapid in situ assay to investigate mitochondrial toxins.
    Steyn SJ, Pieterse DJ, Mienie LJ, Van der Schyf CJ.
    J Biochem Biophys Methods; 2005 Jan 31; 62(1):25-40. PubMed ID: 15656941
    [Abstract] [Full Text] [Related]

  • 15. Deuterium isotope effects for the oxidation of 1-methyl-3-phenyl-3-pyrrolinyl analogues by monoamine oxidase B.
    Pretorius A, Ogunrombi MO, Terre'blanche G, Castagnoli N, Bergh JJ, Petzer JP.
    Bioorg Med Chem; 2008 Oct 01; 16(19):8813-7. PubMed ID: 18799315
    [Abstract] [Full Text] [Related]

  • 16. Cytotoxic effects of MPTP on SH-SY5Y human neuroblastoma cells.
    Song X, Perkins S, Jortner BS, Ehrich M.
    Neurotoxicology; 1997 Oct 01; 18(2):341-53. PubMed ID: 9291484
    [Abstract] [Full Text] [Related]

  • 17. Iron-mediated bioactivation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in glial cultures.
    Di Monte DA, Schipper HM, Hetts S, Langston JW.
    Glia; 1995 Oct 01; 15(2):203-6. PubMed ID: 8567072
    [Abstract] [Full Text] [Related]

  • 18. Type A monoamine oxidase is the target of an endogenous dopaminergic neurotoxin, N-methyl(R)salsolinol, leading to apoptosis in SH-SY5Y cells.
    Yi H, Akao Y, Maruyama W, Chen K, Shih J, Naoi M.
    J Neurochem; 2006 Jan 01; 96(2):541-9. PubMed ID: 16336631
    [Abstract] [Full Text] [Related]

  • 19. Involvement of hepatic aldehyde oxidase in conversion of 1-methyl-4-phenyl-2,3-dihydropyridinium (MPDP+) to 1-methyl-4-phenyl-5,6-dihydro-2-pyridone.
    Yoshihara S, Ohta S.
    Arch Biochem Biophys; 1998 Dec 01; 360(1):93-8. PubMed ID: 9826433
    [Abstract] [Full Text] [Related]

  • 20. R(-)-deprenyl potentiates dopamine-induced cytotoxicity toward catecholaminergic neuroblastoma SH-SY5Y cells.
    Lai CT, Yu PH.
    Toxicol Appl Pharmacol; 1997 Jan 01; 142(1):186-91. PubMed ID: 9007048
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 5.